Approaches to intensified insulin therapy
Klausmann, G.; Herz, R.
Zeitschrift für Gastroenterologie 34(Suppl 2): 69-71
1996
ISSN/ISBN: 0044-2771 PMID: 8767430 Document Number: 467641
Document emailed within 1 workday
Related Documents
Jungmann, E.; Helling, T.; Jungmann, G.; Mertens, C.; Snelting, U. 2001: Intensified conventional insulin therapy in patients with type 2 diabetes mellitus. Positive long-term effects of insulin lispro on metabolic control and microalbuminuria Fortschritte der Medizin. Originalien 118(4): 141-146Keller, U.; Straumann, E.; Berger, W. 1988: Intensified insulin therapy in Type-i diabetes Schweizerische Rundschau für Medizin Praxis 77(9): 213-217
Martin, S. 1998: Intensified insulin therapy in type i diabetes: when and how? Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 92(7): 475-480
Lauritzen, T. 1985: Pharmacokinetic and clinical aspects of intensified subcutaneous insulin therapy Danish Medical Bulletin 32(2): 104-118
Bergis, K. 1985: Intensified conventional insulin therapy--a particular task of the specialty clinic Fortschritte der Medizin 103(19): 511-513
Chaieb, L.; Chadli, M.; Jemni, L.; Chatti, N.; Ghariani, M.T.; Zebidi, A.; Hidar, M.; Djaïdane, A. 1986: Intensified conventional insulin therapy in the diabetic pregnant woman La Tunisie Medicale 64(2): 143-146
Reichard, P. 1991: Intensified treatment of insulin-dependent diabetes results in milder complications Lakartidningen 88(38): 3067-3068
Hamaguchi, T.; Sadahiro, K.; Satoh, T. 2015: Current concept of insulin therapy intensification, and the role of human regular insulin and rapid-acting insulin analogs in insulin treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 73(3): 447-452
Murata, K.; Shiraki, K.; Takase, K.; Nakano, T.; Tameda, Y. 2002: Mono-arthritis following intensified interferon beta therapy for chronic hepatitis C Hepato-Gastroenterology 49(47): 1418-1419
Heber, D.; Molitch, M.E.; Sperling, M.A. 1977: Low-dose continuous insulin therapy for diabetic ketoacidosis. Prospective comparison with "conventional" insulin therapy Archives of Internal Medicine 137(10): 1377-1380
Itoh, H.; Namba, M.; Kono, N.; Tarui, S. 1990: Multiple insulin injection therapy as intensive insulin therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 1015-1021
Matthaei, S.; Hamann, A. 1997: Current insulin therapy. Treatment with new short-acting and retard insulin analogs Fortschritte der Medizin 115(12): 35-6 39
Afanas'eva, S.N. 1982: Insulin therapy and the nature of immunologic reactions to insulin and pancreatic tissue in diabetes mellitus Terapevticheskii Arkhiv 54(10): 30-32
Bringer, J.; Galtier-Dereure, F.; Augustin-Pascalis, I.; Richard, J.L.; Parer-Richard, C.; Mirouze, J.; Jaffiol, C. 1993: Provisional intensive insulin therapy in non-insulin-dependent diabetes resistant to usual treatment Journees Annuelles de Diabetologie de l'Hotel-Dieu 1993: 115-122
Lundershausen, R.; Potthoff, F.; Häuser, C.; Kaiser, M.; Münscher, C. 2006: Human insulin vs. analogs. What is the cost of supplementary insulin therapy? MMW Fortschritte der Medizin 148(45): 42
Korányi, L.; Tamás, G.; Gerö, L.; Halmos, T.; Baranyai, E.; Büki, B. 1981: Glucagon antibodies in the blood of insulin-treated diabetics (effect of monospecific and monocomponent insulin therapy on antibody level) Orvosi Hetilap 122(23): 1371-1374
King, A. 2012: Advances in insulin therapy: a review of insulin degludec Journal of Family Practice 61(5 Suppl): S28-S31
Mozdzan, M.ł; Mozdzan, M.; Loba, J.; Markuszewski, L.; Ruxer, J. 2006: Effect of short-term intensive insulin therapy on daily insulin requirement in poorly controlled type 2 diabetes patients Wiadomosci Lekarskie 59(3-4): 203-207
Ametov, A.S.; Kochergina, I.I.; Ulanova, K.A. 2010: Effect of insulin therapy on insulin resistance and risk for ischemic heart disease and death from cardiovascular pathology in patients with diabetes mellitus, type 2 Terapevticheskii Arkhiv 82(3): 42-46
Geleto, A.; Abate, D.; Egata, G. 2017: Intensified tuberculosis case finding, implementation of isoniazid preventive therapy and associated factors among people living with human immunodeficiency virus at public health facilities of Harari Region, Eastern Ethiopia: A cross-sectional study International Journal of Health Sciences 11(1): 1-8